Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea · Delayed Price · Currency is KRW 13,110
0.00 (0.00%)
At close: Oct 2, 2025
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 280.56 billion as of October 6, 2025. Its market cap has decreased by -8.08% in one year.
Market Cap
280.56B
Enterprise Value
427.03B
Revenue
603.74B
Ranking
n/a
PE Ratio
30.62
Stock Price
13,110.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 280.56B, an increase of 1,453.51%. That is a compound annual growth rate of 11.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 280.56B | -8.14% |
| Dec 30, 2024 | 305.43B | -7.98% |
| Dec 28, 2023 | 331.93B | -15.58% |
| Dec 29, 2022 | 393.20B | 14.64% |
| Dec 30, 2021 | 343.00B | -9.91% |
| Dec 30, 2020 | 380.71B | 13.65% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |